Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue.

Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue. Diabetes. 2006 Mar; 55(3):640-50.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.